Glioblastoma hijacks neuronal mechanisms for brain invasion
- PMID: 35914528
- DOI: 10.1016/j.cell.2022.06.054
Glioblastoma hijacks neuronal mechanisms for brain invasion
Abstract
Glioblastomas are incurable tumors infiltrating the brain. A subpopulation of glioblastoma cells forms a functional and therapy-resistant tumor cell network interconnected by tumor microtubes (TMs). Other subpopulations appear unconnected, and their biological role remains unclear. Here, we demonstrate that whole-brain colonization is fueled by glioblastoma cells that lack connections with other tumor cells and astrocytes yet receive synaptic input from neurons. This subpopulation corresponds to neuronal and neural-progenitor-like tumor cell states, as defined by single-cell transcriptomics, both in mouse models and in the human disease. Tumor cell invasion resembled neuronal migration mechanisms and adopted a Lévy-like movement pattern of probing the environment. Neuronal activity induced complex calcium signals in glioblastoma cells followed by the de novo formation of TMs and increased invasion speed. Collectively, superimposing molecular and functional single-cell data revealed that neuronal mechanisms govern glioblastoma cell invasion on multiple levels. This explains how glioblastoma's dissemination and cellular heterogeneity are closely interlinked.
Keywords: cancer neuroscience; cell heterogeneity; glioblastoma; glutamatergic synapse; neurogliomal synapses; neuron-tumor interaction; tumor cell networks; tumor microtubes.
Copyright © 2022 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests F.W. and W.W. report the patent (WO2017020982A1) “Agents for use in the treatment of glioma.” F.W. is co-founder of DC Europa Ltd (a company trading under the name Divide & Conquer) that is developing new medicines for the treatment of glioma. Divide & Conquer also provides research funding to F.W.’s lab under a research collaboration agreement.
Comment in
-
Invasive glioma cells: The malignant pioneers that follow the current.Cell. 2022 Aug 4;185(16):2846-2848. doi: 10.1016/j.cell.2022.06.033. Cell. 2022. PMID: 35931016
-
Shining a light on tumour behaviour.Nat Rev Cancer. 2022 Dec;22(12):662. doi: 10.1038/s41568-022-00526-6. Nat Rev Cancer. 2022. PMID: 36216887 No abstract available.
Similar articles
-
Tweety-Homolog 1 Drives Brain Colonization of Gliomas.J Neurosci. 2017 Jul 19;37(29):6837-6850. doi: 10.1523/JNEUROSCI.3532-16.2017. Epub 2017 Jun 12. J Neurosci. 2017. PMID: 28607172 Free PMC article.
-
Individual glioblastoma cells harbor both proliferative and invasive capabilities during tumor progression.Neuro Oncol. 2023 Dec 8;25(12):2150-2162. doi: 10.1093/neuonc/noad109. Neuro Oncol. 2023. PMID: 37335907 Free PMC article.
-
[Glioblastomas exploit neuronal properties: a key to new forms of treatment?].Nervenarzt. 2024 Feb;95(2):96-103. doi: 10.1007/s00115-023-01589-y. Epub 2023 Dec 29. Nervenarzt. 2024. PMID: 38157044 Review. German.
-
Characterizing and targeting glioblastoma neuron-tumor networks with retrograde tracing.Cell. 2025 Jan 23;188(2):390-411.e36. doi: 10.1016/j.cell.2024.11.002. Epub 2024 Dec 6. Cell. 2025. PMID: 39644898
-
Neuronal signatures in cancer.Int J Cancer. 2020 Dec 15;147(12):3281-3291. doi: 10.1002/ijc.33138. Epub 2020 Jun 19. Int J Cancer. 2020. PMID: 32510582 Review.
Cited by
-
Therapeutic Targeting of Glioblastoma and the Interactions with Its Microenvironment.Cancers (Basel). 2023 Dec 10;15(24):5790. doi: 10.3390/cancers15245790. Cancers (Basel). 2023. PMID: 38136335 Free PMC article. Review.
-
A phase Ib/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: the GLUGLIO trial protocol.BMC Cancer. 2024 Jan 15;24(1):82. doi: 10.1186/s12885-023-11797-z. BMC Cancer. 2024. PMID: 38225589 Free PMC article.
-
PerSurge (NOA-30) phase II trial of perampanel treatment around surgery in patients with progressive glioblastoma.BMC Cancer. 2024 Jan 26;24(1):135. doi: 10.1186/s12885-024-11846-1. BMC Cancer. 2024. PMID: 38279087 Free PMC article. Clinical Trial.
-
Brain network mapping and glioma pathophysiology.Brain Commun. 2023 Feb 21;5(2):fcad040. doi: 10.1093/braincomms/fcad040. eCollection 2023. Brain Commun. 2023. PMID: 36895956 Free PMC article. Review.
-
Understanding glioblastoma at the single-cell level: Recent advances and future challenges.PLoS Biol. 2024 May 30;22(5):e3002640. doi: 10.1371/journal.pbio.3002640. eCollection 2024 May. PLoS Biol. 2024. PMID: 38814900 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials